Risk of cervical cancer among women who took an HPV test in 1990-1992, a 30-year follow-up study

Long-term follow-up of patients with positive tests for HPV in 1990-1992, comparing HPV status at baseline with the risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) in the follow-up period of 30 years

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN10836802

Enrollment

642

Registered

2020-12-23

Start date

1990-08-18

Completion date

Unknown

Last updated

2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Investigating the risk of CIN3+ in patients with an HPV test at UNN in 1990-1992 Urological and Genital Diseases

Interventions

Observational trial: an exposed cohort consisting of women with a positive HR-HPV test (N=223) was compared to a control cohort consisting of women with a negative HR-HPV test (N=419). During the peri

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All women referred to the HPV outpatient clinic at the University Hospital of Northern Norway (UNN) in 1990-1992, with an HPV test at baseline

Exclusion criteria

Exclusion criteria: History of medical or surgical treatment for cervical cancer.

Design outcomes

Primary

Measure	Time frame
Detection of cervical cancer during follow up period, measured by biopsy and recorded in patient records	—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

Norway

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 22, 2026